Hear experts discuss new developments in Hydroxyurea therapy treatment for sickle cell disease.  You do  not need to be a member of the American Society of              Hematology to participate but registration is required.  FLASCO member,            Dr. Richard Lottenberg, invites all interested to join:

Optimization of Hydroxyurea for the Management of Sickle Cell Disease
Thursday, September 24, 2015
1:00 – 2:00 p.m. (ET)

ASH’s latest webinar will highlight recommendations related to hydroxyurea therapy from the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report, present new data that modifies or expands on some of those recommendations, and review methods for optimizing therapy for individual patients.

Moderator:
John J. Strouse, MD, PhD
Assistant Professor of Hematology, Johns Hopkins Children’s Center, Baltimore, MD

Speakers:
Susan E. Creary, MD
Assistant Professor of Pediatric Hematology/Oncology, Nationwide Children’s Hospital, Columbus, OH

Richard Lottenberg, MD
Professor of Medicine, University of Florida College of Medicine, Gainesville, FL

Amanda Brandow, DO, MS
Assistant Professor, Medical College of Wisconsin, Milwaukee, WI

 ASH Webinars
As part of its efforts to expand digital education offerings as a service to members, ASH began producing a series of webinars in 2014. ASH education webinars feature presentations by experts in the field, cover current information on how to best diagnose and care for patients, and provide time for speakers and participants to discuss relevant issues during a question-and- answer session.
ASH webinars are offered live and recordings are archived on ASH On Demand.